MNKD Live signals | Maximize Profits with Getagraph.com

SELL 92221 min ago

@ $3.58

Issued: 14 Feb 2024 @ 14:32

Return: 14.13%

Previous signal: Feb 14 - 13:57

Previous signal: Buy

Return: 1.56 %

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States...

Stats
Today's Volume	1.29M
Average Volume	2.98M
Market Cap	1.10B
EPS	$0 ( 2024-02-27 )
Next earnings date	( $0.0200 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-102.00
ATR14	$0.00500 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-27	Sabella Lauren M	Sell	17 084	Common Stock, $.01 Par Value
2024-02-04	Tross Stuart A	Buy	15 290	Common Stock, $0.01 Par Value
2023-12-31	Tross Stuart A	Buy	1 006	Common Stock, $0.01 Par Value
2023-06-30	Tross Stuart A	Buy	4 012	Common Stock, $0.01 Par Value
2024-02-04	Blank Burkhard	Buy	152 905	Common Stock, $0.01 Par Value

INSIDER POWER
30.59
Last 96 transactions
Buy: 5 265 399 \| Sell: 2 722 728

Volume Correlation

Long: -0.58 (weak negative)

Short: 0.35 (neutral)

Signal:(21.001) Neutral

MannKind Corp Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MannKind Corp Correlation - Currency/Commodity

-0.06
( neutral )

-0.13
( neutral )

0.00
( neutral )

-0.09
( neutral )

MannKind Corp Financials

Annual	2023
Revenue:	$198.96M
Gross Profit:	$136.19M (68.45 %)
EPS:	$-0.0447

Q4	2023
Revenue:	$58.47M
Gross Profit:	$40.41M (69.10 %)
EPS:	$0.00520

Q3	2023
Revenue:	$51.25M
Gross Profit:	$37.00M (72.19 %)
EPS:	$0.00640

Q2	2023
Revenue:	$48.61M
Gross Profit:	$34.37M (70.71 %)
EPS:	$-0.0198

Financial Reports:

No articles found.

MannKind Corp

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.